Mycoplasma genitalium in chronic non-gonococcal urethritis. 2004

D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
Division of Medicine, Imperial College London, St Mary's Hospital, London W2 1NY, UK.

Seventy-eight men with a history of chronic urethritis were referred for investigation. Of 52 men diagnosed as having persistent or recurrent non-gonococcal urethritis (NGU) at the time of referral, 11 (21%) were infected with Mycoplasma genitalium and three with Chlamydia trachomatis. Men who were M. genitalium-positive had not previously received less antibiotic, in terms of treatment duration, than those who were M. genitalium-negative, suggesting a possible resistance to the antibiotics given. In the current investigation, of 11 M. genitalium-positive men with persistent or recurrent NGU who were treated for four to six weeks with erythromycin, 500 mg four times daily, nine (82%) responded clinically and microbiologically, but later six relapsed without M. genitalium being detected. The results of observing and investigating a patient for about one year, the only one to have concurrent chlamydial and mycoplasmal infections, is presented, a feature being the intermittent persistence of the mycoplasma.

UI MeSH Term Description Entries
D008131 London The capital of the United Kingdom. It is located in England.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002692 Chlamydia trachomatis Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
January 1995, International journal of STD & AIDS,
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
March 1994, Lancet (London, England),
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
January 1994, Lancet (London, England),
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
December 2008, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
October 1994, Genitourinary medicine,
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
August 2001, Sexually transmitted infections,
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
July 2012, Expert review of anti-infective therapy,
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
November 2005, International journal of STD & AIDS,
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
February 2011, Sexually transmitted infections,
D Taylor-Robinson, and C B Gilroy, and B J Thomas, and P E Hay
August 2021, Sexually transmitted infections,
Copied contents to your clipboard!